Chondroprotec® (Polysulfated Glycosaminoglycan) 1000 mg / 10 ml Vial

Chondroprotec is a high-potency veterinary polysulfated glycosaminoglycan (PSGAG) injectable solution formulated to protect joint cartilage, inhibit cartilage-degrading enzymes, and support the management of degenerative joint disease, traumatic arthritis, and osteoarthritis in dogs, cats, and horses operating under professional veterinary supervision. Combining a concentrated glycosaminoglycan structure that closely mimics natural synovial fluid components, this professional-grade therapeutic preparation delivers targeted intra-articular and systemic joint restoration. Because of its potent pharmacological profile and systemic impact, the administration of Chondroprotec requires precise clinical evaluation, individualized weight-based dosing, and strict adherence to professional veterinary guidelines.

What Is Chondroprotec 1000 mg / 10 ml?

Chondroprotec is a specialized veterinary chondroprotective compound formulated for parenteral administration under professional clinical supervision.

Active Ingredients and Formulation

• Active Component: Polysulfated Glycosaminoglycan (PSGAG) at a concentration of 100 mg/ml (totaling 1000 mg per 10 ml multi-dose vial). It stimulates collagen and proteoglycan synthesis while inhibiting destructive joint enzymes like matrix metalloproteinases (MMPs).

• Vehicle and Presentation: Formulated as a sterile, clear injectable solution supplied in a secure 10 ml multi-dose glass vial designed for veterinary aseptic dispensing and targeted administration.

What Is It Used For?

Primary Veterinary Indications

• Osteoarthritis and Degenerative Joint Disease: Routinely utilized by veterinarians to reduce joint pain, diminish lameness, and improve mobility in dogs, cats, and horses suffering from chronic wear-and-tear or age-related joint degeneration.

• Trauma and Surgery Recovery: Formulated to accelerate cartilage repair and reduce inflammation following orthopedic joint surgeries or acute joint trauma.

• Synovial Fluid Restoration: Replenishes the viscosity and protective lubricating quality of joint synovial fluid, minimizing friction and further cartilage erosion.

Administration and Dosage Considerations

Route and Dosing

• Route of Administration: Administered via intramuscular (I.M.) injection in dogs, cats, and horses (or intra-articularly in horses under strictly controlled surgical aseptic conditions by a licensed veterinarian).

• Standard Canine & Feline Dosage Reference: Typically administered at 2 mg per kg of body weight, given twice weekly for up to 4 weeks (maximum of 8 injections) as directed by a veterinarian.

• Standard Equine Dosage Reference: Typically administered at 500 mg (5 ml) via intramuscular injection every 4 days for a total of 5 injections.

• Veterinary Supervision: Exact dosage schedules, injection frequencies, and treatment courses must be determined and monitored exclusively by a qualified veterinarian based on clinical severity.

Important Safety Information

• Contraindications: Do not administer to animals with known hypersensitivity to polysulfated glycosaminoglycan or heparin (due to structural anticoagulant similarities). Contraindicated in animals with active bleeding disorders, severe renal impairment, or pre-existing infection within the target joint.

• Side Effects and Precautions: Generally exceptionally well tolerated. Mild, transient local discomfort at the injection site can occasionally occur. Because PSGAG possesses mild anticoagulant properties, use with caution in animals undergoing concurrent anticoagulant therapy or scheduled for surgery.

• Withdrawal Periods: Mandatory meat withdrawal intervals established by local regulatory authorities must be observed prior to marketing animal products from treated food-producing equines for human consumption.

• Professional Guidance: Due to its active systemic pharmacological profile, use must be strictly supervised by a licensed animal health professional.

Storage and Handling

• Store at controlled room temperature between 15°C and 30°C (59°F to 86°F), protected from direct sunlight, excessive heat, and freezing.

• Maintain strict aseptic technique when puncturing multi-dose vials to prevent microbial contamination during repeated use.

• Keep securely out of reach of children, unauthorized individuals, feedstuffs, and animals at all times.

Frequently Asked Questions

What is Chondroprotec used for?

It is a professional veterinary PSGAG injection utilized to treat osteoarthritis, reduce joint inflammation, and stimulate cartilage repair in dogs, cats, and horses.

What is the active ingredient?

It contains 1000 mg of Polysulfated Glycosaminoglycan (PSGAG) per 10 ml vial, which inhibits cartilage-degrading enzymes and lubricates joint spaces.

How is Chondroprotec administered?

It is primarily administered via intramuscular injection according to species-specific weight-based dosing schedules under veterinary supervision.

Order Chondroprotec 1000mg x 10ml Online

Chondroprotec 1000mg x 10ml Vial is available for order through our platform subject to full compliance with local regulatory and veterinary prescription requirements. For assistance regarding stock availability, secure ordering protocols, or delivery options, please contact our customer support team.